Study of Qiliqiangxin Capsule to Treat Dilated Cardiomyopathy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 374 participants.

Also called NCT01293903

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 374 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01293903
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01293903. Randomized; quadruple masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2015-12-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of Qiliqiangxin Capsule to Treat Dilated Cardiomyopathy
Acronym
QLQX-DCM
Condition
Dilated Cardiomyopathy
Condition
Heart Failure
Intervention (Drug)
Qiliqiangxin capsule
Intervention (Drug)
Placebo
Lead sponsor
Huazhong University of Science and Technology (class: other)
Collaborator
Fudan University (class: other)
Collaborator
First Affiliated Hospital of Harbin Medical University (class: other)
Collaborator
First Affiliated Hospital Xi'an Jiaotong University (class: other)
Collaborator
Shandong Provincial Hospital (class: other government)
Collaborator
The First Affiliated Hospital with Nanjing Medical University (class: other)
Collaborator
First Affiliated Hospital of Guangxi Medical University (class: other)
Collaborator
The First Affiliated Hospital of Zhengzhou University (class: other)
Collaborator
Ministry of Science and Technology of the People´s Republic of China (class: other government)
Collaborator
China National Center for Cardiovascular Diseases (class: other government)
Collaborator
RenJi Hospital (class: other)
Collaborator
Second Affiliated Hospital of Xi'an Jiaotong University (class: other)
Collaborator
The Second Affiliated Hospital of Harbin Medical University (class: other)
Collaborator
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (class: other)
Collaborator
Tongji Hospital (class: other)
Collaborator
Wuhan University (class: other)
Collaborator
Henan Provincial People's Hospital (class: other)
Collaborator
Jining Medical University (class: other)
Collaborator
Second Hospital of Shanxi Medical University (class: other)
Collaborator
Shanxi Cardiovascular Hospital (class: other)
Collaborator
Wuhan Pu-Ai Hospital (class: other)
Collaborator
Tianyou Hospital Affiliated to Wuhan University of Science and Technology (class: other)
Collaborator
Yunyang Medical College (class: other)
Collaborator
China Three Gorges University, Yichang, China (class: other)
Collaborator
Xiangyang Central Hospital (class: other)
Collaborator
Wuhan No.1 Hospital (class: other)
Collaborator
Jingzhou Central Hospital (class: other)

Registry records

Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry organizations 22

Record details

Record id
cardio:ct-nct01293903
Content hash
73936f87038b0026b6452b2c7119b0caf8fcf2e744639cd659eb82eab068749e